By Maegan Murray Credit: Illustration by Mike Perkins and Nathan Johnson | Pacific Northwest National Laboratory By Maegan Murray Scientists have spent...
The firm will now able to conduct research trials in the United States. The post Filament Health’s psychedelic drug candidate gains FDA nod appeared...
VANCOUVER, BC, Jan. 31, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage...
SAN FRANCISCO – Jaguar Health, Inc. (NASDAQ: JAGX) today announced that a preclinical study in mice initiated in Brazil by Magdalena Biosciences,...
Health and wellness company Bioxyne has disclosed group revenue of ~$2.56 million for Q2 FY24, propelling the company's annualised sales ... Read More The...
Psychedelic Invest publishes its annual psychedelics industry report summarizing all of the events of 2023.
PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development,...
The Psychedelic Education Market is Expanding Rapidly This rapid expansion is occurring in response to growth— both real and perceived- in the greater...
Discover the transformative synergy of forest bathing and psychedelics for a deeper connection with nature and improved well-being.
The firm will start building out a sales pipeline to eventually sell mushrooms “if and when regulations permit." The post Red Light Holland targets U.S....